Rsearch progress on the relationship between aging and microbiota in sarcopenia

Area of Science:

• Gerontology
• Immunology
• Microbiology

Background:

• Sarcopenia is a prevalent age-related skeletal muscle disease with severe health consequences.
• The increasing global aging population exacerbates the prevalence and impact of sarcopenia.
• Current treatments for sarcopenia are limited, highlighting the need for novel therapeutic strategies.

Purpose of the Study:

• To explore the complex relationship between sarcopenia, immunosenescence, and gut microbiota dysbiosis.
• To identify potential diagnostic and therapeutic targets for sarcopenia based on immune and microbial changes.
• To facilitate early detection, diagnosis, and intervention for sarcopenia to promote healthy aging.

Main Methods:

• This review synthesizes current research on the interplay between aging, the immune system, and the gut microbiome in the context of sarcopenia.
• It examines the role of T cell alterations in immunosenescence and their connection to sarcopenia.
• The review analyzes evidence linking intestinal microbiota dysbiosis to the development and progression of sarcopenia.

Main Results:

• Immunosenescence, characterized by T cell dysregulation, is increasingly recognized as a contributor to sarcopenia.
• Alterations in the gut microbiota composition (dysbiosis) are associated with age-related muscle decline.
• Both immunosenescence and gut dysbiosis represent promising, yet understudied, therapeutic avenues for sarcopenia.

Conclusions:

• The intricate relationship between gut microbiota dysbiosis, immunosenescence, and sarcopenia offers potential targets for future interventions.
• Further research into these mechanisms could pave the way for early detection and effective treatment of sarcopenia.
• Targeting microbial and immune pathways may help mitigate sarcopenia and extend healthy lifespan.